Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, China.
National Clinical Research Center for Obstetrical and Gynecology, Peking University Third Hospital, Beijing, China.
Front Endocrinol (Lausanne). 2022 Jun 30;13:924070. doi: 10.3389/fendo.2022.924070. eCollection 2022.
Emerging evidence has shown that fertilization (IVF) is associated with higher risks of certain placental abnormalities or complications, such as placental abruption, preeclampsia, and preterm birth. However, there is a lack of large population-based analysis focusing on placental abnormalities or complications following IVF treatment. This study aimed to estimate the absolute risk of placental abnormalities or complications during IVF-conceived pregnancy.
We conducted a retrospective cohort study of 16 535 852 singleton pregnancies with delivery outcomes in China between 2013 and 2018, based on the Hospital Quality Monitoring System databases. Main outcomes included placental abnormalities (placenta previa, placental abruption, placenta accrete, and abnormal morphology of placenta) and placenta-related complications (gestational hypertension, preeclampsia, eclampsia, preterm birth, fetal distress, and fetal growth restriction (FGR)). Poisson regression modeling with restricted cubic splines of exact maternal age was used to estimate the absolute risk in both the IVF and non-IVF groups.
The IVF group (n = 183 059) was more likely than the non-IVF group (n = 16 352 793) to present placenta previa (aRR: 1.87 [1.83-1.91]), placental abruption (aRR: 1.16 [1.11-1.21]), placenta accrete (aRR: 2.00 [1.96-2.04]), abnormal morphology of placenta (aRR: 2.12 [2.07 to 2.16]), gestational hypertension (aRR: 1.55 [1.51-1.59]), preeclampsia (aRR: 1.54 [1.51-1.57]), preterm birth (aRR: 1.48 [1.46-1.51]), fetal distress (aRR: 1.39 [1.37-1.42]), and FGR (aRR: 1.36 [1.30-1.42]), but no significant difference in eclampsia (aRR: 0.91 [0.80-1.04]) was found. The absolute risk of each outcome with increasing maternal age in both the IVF and non-IVF group presented two patterns: an upward curve showing in placenta previa, placenta accreta, abnormal morphology of placenta, and gestational hypertension; and a J-shape curve showing in placental abruption, preeclampsia, eclampsia, preterm birth, fetal distress, and FGR.
IVF is an independent risk factor for placental abnormalities and placental-related complications, and the risk is associated with maternal age. Further research is needed to evaluate the long-term placenta-related chronic diseases of IVF patients and their offspring.
新出现的证据表明,体外受精(IVF)与某些胎盘异常或并发症的风险增加有关,例如胎盘早剥、子痫前期和早产。然而,目前缺乏针对 IVF 治疗后胎盘异常或并发症的大型基于人群的分析。本研究旨在估计 IVF 妊娠期间胎盘异常或并发症的绝对风险。
我们基于中国医院质量监测系统数据库,对 2013 年至 2018 年期间 16535852 例单胎分娩结局的 IVF 受孕和非 IVF 受孕妊娠进行了回顾性队列研究。主要结局包括胎盘异常(前置胎盘、胎盘早剥、胎盘植入和胎盘形态异常)和胎盘相关并发症(妊娠期高血压、子痫前期、子痫、早产、胎儿窘迫和胎儿生长受限(FGR))。使用精确母体年龄的受限立方样条的泊松回归模型来估计 IVF 组和非 IVF 组的绝对风险。
IVF 组(n=183059)比非 IVF 组(n=16352793)更有可能出现前置胎盘(ARR:1.87[1.83-1.91])、胎盘早剥(ARR:1.16[1.11-1.21])、胎盘植入(ARR:2.00[1.96-2.04])、胎盘形态异常(ARR:2.12[2.07-2.16])、妊娠期高血压(ARR:1.55[1.51-1.59])、子痫前期(ARR:1.54[1.51-1.57])、早产(ARR:1.48[1.46-1.51])、胎儿窘迫(ARR:1.39[1.37-1.42])和 FGR(ARR:1.36[1.30-1.42]),但子痫(ARR:0.91[0.80-1.04])无显著差异。在 IVF 组和非 IVF 组中,随着母体年龄的增加,每种结局的绝对风险呈现两种模式:一种是呈上升曲线的前置胎盘、胎盘植入、胎盘形态异常和妊娠期高血压;另一种是呈 J 形曲线的胎盘早剥、子痫前期、子痫、早产、胎儿窘迫和 FGR。
IVF 是胎盘异常和胎盘相关并发症的独立危险因素,且该风险与母体年龄相关。需要进一步研究来评估 IVF 患者及其后代的长期胎盘相关慢性疾病。